Research programme: oral insulin/insulin sensitiser - Diabetology
Alternative Names: CombulinLatest Information Update: 04 Nov 2017
At a glance
- Originator Diabetology
- Class Insulins
- Mechanism of Action Ornithine decarboxylase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in United Kingdom (PO, Tablet)
- 30 Sep 2015 Preclinical development is ongoing in United Kingdom (Diabetology pipeline, September 2015)
- 30 May 2005 Preclinical trials in Type-2 diabetes mellitus in United Kingdom (PO)